Johnson & Johnson Raises FY2026 Adj EPS Guidance from $10.96-$11.11 to $11.05-$11.15 vs $11.08 Est; Raises FY2026 Sales Guidance from $100.800B-$101.400B to $101.000B-$101.400B vs $101.296B Est

Johnson & Johnson has increased its FY2026 adjusted EPS guidance from a range of $10.96-$11.11 to $11.05-$11.15, compared to an analyst estimate of $11.08. Additionally, the company raised its FY2026 sales outlook from $100.800 billion-$101.400 billion to $101.000 billion-$101.400 billion, against an estimate of $101.296 billion.